NCT00393029
- Conditions
- Adenocarcinoma, Anti-p53 TCR-Gene, Carcinoma, +18 more
- Locations
-
- National Institutes of Health Bethesda, Maryland, United States
Clinical trial condition
Anti-p53 TCR-Gene
Explore clinical trials studying Anti-p53 TCR-Gene. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies